Cited by 458Sexual function and dysfunction studiesHormonal and reproductive studiesMenopause: Health Impacts and Treatments

Safety and Efficacy of a Testosterone Patch for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women: A Randomized, Placebo-Controlled Trial

Braunstein, Glenn D., Sundwall, Dale A., Katz, Molly, Shifren, Jan L., Buster, John E., Simon, James A., Bachman, Gloria, Aguirre, Oscar A. +4 more·2005·Archives of Internal Medicine

Abstract

BACKGROUND: Oophorectomy reduces serum testosterone levels. We studied the efficacy and safety of transdermal testosterone in treating hypoactive sexual desire disorder in surgically menopausal women. METHODS: A 24-week, randomized, double-blind, placebo-controlled, parallel-group, multicenter trial was conducted in women (aged 24-70 years) who developed distressful low sexual desire after bilateral salpingo-oophorectomy and hysterectomy and who were receiving oral estrogen therapy. Women were randomized to receive placebo (n = 119) or testosterone patches in dosages of 150 microg/d (n = 107), 300 microg/d (n = 110), or 450 microg/d (n = 111) twice weekly for 24 weeks. Sexual desire and frequency of satisfying sexual activity were primary efficacy outcome measures. RESULTS: Of the 447 women randomized, 318 (71%) completed the trial. Compared with placebo, women receiving the 300-microg/d testosterone patch had significantly greater increases from baseline in sexual desire (67% vs 48%; P = .05) and in frequency of satisfying sexual activity (79% vs 43%; P = .049). The 150-microg/d group showed no evidence of a treatment effect. The 450-microg/d group also was not statistically different from the 300-microg/d or placebo groups. Marginally significant linear dose-response trends were observed for total satisfying sexual activity and sexual desire at 24 weeks (P = .06 and .06, respectively). Adverse events occurred with similar frequency in both groups; no serious safety concerns were observed. CONCLUSIONS: The 300-microg/d testosterone patch increased sexual desire and frequency of satisfying sexual activity and was well tolerated in women who developed hypoactive sexual desire disorder after surgical menopause.

Integrity signals

Registry

Crossref · 10.1001/archinte.165.14.1582

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • By heightening sexual desire in the less aroused partner or reducing it in the more aroused partner, the discrepancy could be minimized, possibly softening a major source of relationship strain.

    “By heightening sexual desire in the less aroused partner (by using testosterone, for instance, see Braunstein et al. 2005; Sherwin 2002; Sherwin and Gelfand 1987; Sherwin et al. 1985) or reducing it in the more aroused partner, the discrepancy could be minimized, possibly softening a major source of relationship strain.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Braunstein, G. D., Sundwall, D. A., Katz, M., Shifren, J. L., Buster, J. E., Simon, J. A., Bachman, G., Aguirre, O. A., Lucas, J. D., Rodenberg, C., Buch, A., & Watts, N. B.
Affiliations
Cedars-Sinai Medical Center (US)
Venue
Archives of Internal Medicine
Published
2005-07-25
Volume
165
Issue
14
Pages
1582
ISSN
0003-9926 (ISSN-L)
OpenAlex
W2154434149
Cited by
458
References
22
Citations by year
2026: 4 · 2025: 3 · 2024: 4 · 2023: 8 · 2022: 12 · 2021: 16 · 2020: 12 · 2019: 14 · 2018: 19 · 2017: 19 · 2016: 16 · 2015: 20 · 2014: 21 · 2013: 20 · 2012: 29
FWCI
26.08
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Rutgers University Community Repository (Rutgers University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
hypoactive sexual desire disorder, testosterone patch, transdermal testosterone, surgical menopause, oophorectomy, hysterectomy, sexual desire, sexual frequency, dose-response relationship, adverse events, hormone replacement therapy
MeSH terms
Administration, Cutaneous, Adult, Aged, Androgens, Dose-Response Relationship, Drug, Double-Blind Method, Estrogens, Female, Humans, Hysterectomy, Menopause, Premature, Middle Aged, Ovariectomy, Sexual Behavior, Gonadal Steroid Hormones, Testosterone, Treatment Outcome, Sexual Dysfunctions, Psychological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review